| |
| |
|
| Insider
Information: |
Stonehouse Jon P |
| Relationship: |
Director |
| City: |
Birmingham |
| State: |
AL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,331,856 |
|
|
Indirect Shares
|
40,000 |
|
|
| Direct
Value |
$7,672,814 |
|
|
|
Indirect Value
|
$271,600 |
|
|
| Total
Shares |
1,371,856 |
|
|
| Total
Value |
$7,944,414 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 16.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
President & CEO, Direc... |
2024-05-13 |
1,127,770 |
2024-05-13 |
40,000 |
Premium* |
|
|
Bellicum Pharmaceuticals, Inc |
BLCM |
Director |
2023-01-03 |
204,086 |
2018-11-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2014-05-09 |
4 |
D |
$7.70 |
$232,648 |
D/D |
(30,214) |
640,445 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2015-01-01 |
4 |
D |
$12.16 |
$68,728 |
D/D |
(5,652) |
664,888 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2015-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,400 |
670,540 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2015-01-20 |
4 |
D |
$11.17 |
$118,491 |
D/D |
(10,608) |
654,280 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2015-03-01 |
4 |
D |
$10.20 |
$52,204 |
D/D |
(5,118) |
650,869 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2015-06-19 |
4 |
S |
$15.02 |
$300,400 |
D/D |
(20,000) |
650,869 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2015-06-19 |
4 |
OE |
$1.20 |
$24,000 |
D/D |
20,000 |
670,869 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2015-07-15 |
4 |
OE |
$11.81 |
$399,981 |
D/D |
33,868 |
684,737 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2015-07-15 |
4 |
D |
$15.67 |
$399,992 |
D/D |
(25,526) |
659,211 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2016-01-01 |
4 |
D |
$10.32 |
$83,499 |
D/D |
(8,091) |
652,230 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2016-01-20 |
4 |
OE |
$4.15 |
$99,998 |
D/D |
24,096 |
676,326 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2016-01-20 |
4 |
D |
$7.55 |
$80,211 |
D/D |
(10,624) |
665,702 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2016-03-01 |
4 |
D |
$2.13 |
$5,881 |
D/D |
(2,761) |
664,585 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2017-01-01 |
4 |
D |
$6.33 |
$54,406 |
D/D |
(8,595) |
655,990 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2017-01-20 |
4 |
D |
$5.95 |
$62,903 |
D/D |
(10,572) |
645,418 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2018-01-01 |
4 |
D |
$4.91 |
$13,336 |
D/D |
(2,716) |
647,951 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2018-01-20 |
4 |
D |
$5.59 |
$53,575 |
D/D |
(9,584) |
638,367 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2018-02-28 |
4 |
OE |
$3.26 |
$185,654 |
D/D |
56,949 |
698,316 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2018-02-28 |
4 |
D |
$4.97 |
$214,823 |
D/D |
(43,224) |
655,092 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2018-05-17 |
4 |
OE |
$1.42 |
$100,006 |
D/D |
70,427 |
725,519 |
0 |
- |
|
| BLCM |
Bellicum Pharmaceuticals,... |
Director |
– • – |
2018-11-09 |
4 |
B |
$4.56 |
$45,600 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2018-12-03 |
4 |
AS |
$9.12 |
$729,600 |
D/D |
(80,000) |
727,674 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2018-12-03 |
4 |
OE |
$1.20 |
$96,000 |
D/D |
80,000 |
807,674 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2019-01-01 |
4 |
D |
$8.07 |
$28,794 |
D/D |
(3,568) |
724,106 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
President & CEO |
• • – |
2019-11-18 |
4 |
B |
$1.45 |
$72,500 |
D/D |
50,000 |
778,086 |
2.81 |
- |
|
80 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
